Meghmani Organics Limited (MOL) AI Stock Analysis

• Market Cap: ₹20.56B
• Dividend Yield: N/A
• Average Volume (3M): 88.76K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.29
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: IN
• Employees: 1,720
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 0.50
• Shares Outstanding: 254,314,210
• 10 Day Avg. Volume: 114,038
• 30 Day Avg. Volume: 88,762
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹83.00
• Price Target Upside: 2.67% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 49 Neutral
• Price Target: ₹83.00 ▲(2.67% Upside)

The overall stock score for Meghmani Organics Limited is primarily impacted by its weak financial performance, characterized by declining revenues and negative cash flows. Technical analysis suggests a bearish trend, while valuation metrics indicate potential overvaluation due to recent losses. The absence of earnings call data and corporate events leaves these areas unaddressed.

Meghmani Organics Limited Business Overview & Revenue Model

Company Description

Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. It offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. The company also provides agrochemical products comprises insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil; herbicides, such as triclopyr butoxy ethyl ester, as well as 2,4-D acid tech, sodium salt WP/SP, and EsterTech; intermediates, including cypermethric acid chloride, meta phenoxy benzaldehyde, meta phenoxy benzyl alcohol, monochloroacetic acid, high trans cypermethric acid chloride, and high cis cypermethric acid chloride; and technical and formulations that are used in crop protection, veterinary, public health, and wood protection applications. Meghmani Organics Limited was founded in 1986 and is based in Ahmedabad, India.

How the Company Makes Money

Meghmani Organics Limited generates revenue primarily through the production and sale of its chemical products. The company's key revenue streams include the sale of agrochemicals, which are used extensively in the agriculture sector to protect crops and enhance yields, and pigments, which are used in industries like textiles and plastics for coloring purposes. The company also leverages strategic partnerships and global distribution networks to expand its market reach and optimize its supply chain, contributing significantly to its earnings. Additionally, Meghmani Organics benefits from economies of scale in its manufacturing operations, allowing it to maintain competitive pricing and profitability.

Meghmani Organics Limited Financial Statement Overview

Summary

Meghmani Organics Limited is facing financial challenges characterized by declining revenues, negative net income, and high leverage. While there are some improvements in operational margins, the overall financial health is strained by negative cash flows and profitability inefficiencies.

Income Statement

The company displays declining revenue with negative growth in the recent year. Gross and net profit margins have been volatile, with the latest year showing a negative net income, impacting the overall profitability. While the EBIT margin has improved, EBITDA margin remains relatively low, indicating potential operational inefficiencies.

Balance Sheet

The balance sheet shows a high debt-to-equity ratio, suggesting increased leverage and potential financial risk. The equity ratio is moderate, reflecting a balanced asset financing structure. Return on equity has been negative recently, indicating challenges in generating shareholder value.

Cash Flow

The cash flow statement reveals negative free cash flow over the past years, signaling potential liquidity issues. The operating cash flow is insufficient to cover capital expenditures, affecting the company's ability to fund operations without external financing. The free cash flow to net income ratio highlights a disconnect between profitability and cash generation.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	20.80B	21.24B	25.57B	15.48B	24.73B	16.12B
Gross Profit	7.65B	8.60B	10.42B	3.17B	10.01B	6.93B
EBITDA	1.66B	1.87B	4.10B	119.50M	4.81B	3.11B
Net Income	-106.01M	-106.01M	2.38B	-1.06B	3.04B	1.86B
Balance Sheet
Total Assets	30.85B	30.85B	31.98B	30.40B	27.98B	19.74B
Cash, Cash Equivalents and Short-Term Investments	311.77M	311.77M	1.52B	330.74M	117.22M	1.23B
Total Debt	8.29B	8.29B	8.24B	8.37B	4.99B	2.68B
Total Liabilities	15.70B	15.70B	15.29B	15.12B	13.31B	8.01B
Stockholders Equity	15.15B	15.15B	16.69B	15.28B	14.66B	11.73B
Cash Flow
Free Cash Flow	0.00	-226.88M	-2.61B	-165.29M	-1.79B	1.24B
Operating Cash Flow	0.00	662.22M	2.04B	2.50B	648.32M	3.33B
Investing Cash Flow	0.00	309.70M	-4.18B	-1.78B	-1.33B	-3.07B
Financing Cash Flow	0.00	-913.88M	2.34B	-854.77M	577.19M	-142.40M

Meghmani Organics Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 80.84
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Negative. The current price of 80.84 is below the 20-day moving average (MA) of 82.86, below the 50-day MA of 87.56, and below the 200-day MA of 81.29, indicating a bearish trend. The MACD of -0.64 indicates Negative momentum. The RSI at 37.83 is Neutral, neither overbought nor oversold. The STOCH value of 34.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MOL.

Meghmani Organics Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FCL	68 Neutral	28.67B	27.52	14.80%	0.32%	-8.66%	-17.79%
IOLCP	68 Neutral	30.49B	29.03	5.99%	0.77%	2.73%	-11.40%
DCW	57 Neutral	20.27B	58.01	2.93%	0.15%	2.24%	181.90%
TATVA	55 Neutral	23.64B	330.43	0.77%	0.10%	2.47%	-72.80%
TNPL	54 Neutral	10.37B	-40.53	0.18%	2.00%	-0.66%	-125.23%
MOL	49 Neutral	₹20.56B	―	―	―	―	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%

Meghmani Organics Limited Corporate Events

Meghmani Organics Approves Key Resolutions at 6th AGM

Meghmani Organics Limited held its 6th Annual General Meeting on June 28, 2025, where all resolutions were approved with the requisite majority. The meeting, conducted via video conferencing, included the adoption of audited financial statements and the reappointment of directors, reflecting the company’s commitment to transparency and governance.